Siemens Healthineers AG Share Price
Equities
SHL
DE000SHL1006
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
After hours 12:54:11 am | |||
| 44.52 EUR | -0.29% |
|
44.30 | -0.48% |
| Capitalization | 4.98TCr 5.85TCr 4.62TCr 4.34TCr 8.08TCr 5,32000Cr 8.67TCr 53TCr 21TCr 2,53000Cr 22TCr 21TCr 9,23100Cr | P/E ratio 2026 * |
21.5x | P/E ratio 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise value | 6.07TCr 7.12TCr 5.62TCr 5.29TCr 9.85TCr 6,48200Cr 11TCr 65TCr 26TCr 3,08200Cr 27TCr 26TCr 11,24800Cr | EV / Sales 2026 * |
2.51x | EV / Sales 2027 * | 2.32x |
| Free-Float |
23.56% | Yield 2026 * |
2.33% | Yield 2027 * | 2.65% |
Last Transcript: Siemens Healthineers AG
| 1 day | -0.77% | ||
| 1 week | -5.22% | ||
| Current month | -0.89% | ||
| 1 month | +0.13% | ||
| 3 months | -7.96% | ||
| 6 months | -2.79% | ||
| Current year | -0.89% |
| 1 week | 44.24 |  | 47.26 |
| 1 month | 44.02 | | 47.26 |
| Current year | 44.02 | | 47.26 |
| 1 year | 40.97 | | 58.48 |
| 3 years | 40.97 | | 58.48 |
| 5 years | 40.32 | | 67.66 |
| 10 years | 28.5 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bernhard Montag
CEO | Chief Executive Officer | 56 | 01/02/2015 |
Jochen Schmitz
DFI | Director of Finance/CFO | 60 | 01/12/2017 |
Peter Schardt
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 01/03/2018 | |
| Chairman | 64 | 01/12/2019 | |
Marion Helmes
BRD | Director/Board Member | 60 | 01/03/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 1.11% | 962 M€ | |
| +1.73% | 1.11% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.29% | -5.22% | -14.55% | -7.90% | 5.8TCr | |
| -0.08% | +1.76% | +7.81% | +4.06% | 23TCr | |
| -1.47% | -6.19% | -12.76% | +105.25% | 19TCr | |
| +0.01% | +0.32% | -3.19% | -13.88% | 17TCr | |
| +3.67% | -3.36% | -9.84% | +99.43% | 13TCr | |
| -1.05% | -0.38% | +19.37% | +5.33% | 4.89TCr | |
| -2.94% | -7.21% | -11.01% | -12.92% | 3.96TCr | |
| -0.73% | +0.44% | +3.23% | +8.98% | 3.75TCr | |
| -3.52% | -6.91% | -9.65% | +18.19% | 3.72TCr | |
| -1.42% | -1.22% | -13.97% | -40.32% | 3.48TCr | |
| Average | -0.82% | -3.90% | -4.46% | +16.62% | 9.75TCr | |
| Weighted average by Cap. | -0.24% | -4.05% | -3.57% | +31.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.42TCr 2.83TCr 2.24TCr 2.1TCr 3.92TCr 2,57900Cr 4.2TCr 26TCr 10TCr 1,22600Cr 11TCr 10TCr 4,47500Cr | 2.56TCr 3.01TCr 2.38TCr 2.23TCr 4.16TCr 2,73800Cr 4.46TCr 27TCr 11TCr 1,30200Cr 11TCr 11TCr 4,75100Cr |
| Net income | 230.87Cr 270.88Cr 213.91Cr 201.18Cr 374.47Cr 25TCr 401.68Cr 2.47TCr 975.48Cr 12TCr 1.02TCr 994.96Cr 43TCr | 269.44Cr 316.13Cr 249.64Cr 234.79Cr 437.03Cr 29TCr 468.79Cr 2.88TCr 1.14TCr 14TCr 1.19TCr 1.16TCr 50TCr |
| Net Debt | 1.09TCr 1.28TCr 1.01TCr 948.34Cr 1.77TCr 1,16200Cr 1.89TCr 12TCr 4.6TCr 55TCr 4.79TCr 4.69TCr 2,01700Cr | 973.88Cr 1.14TCr 902.34Cr 848.65Cr 1.58TCr 1,04000Cr 1.69TCr 10TCr 4.11TCr 49TCr 4.28TCr 4.2TCr 1,80500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 44.52 € | -0.29% | 6,77,875 |
| 19/26/19 | 44.65 € | -3.56% | 7,29,286 |
| 16/26/16 | 46.30 € | -1.07% | 6,51,069 |
| 15/26/15 | 46.80 € | -0.53% | 7,57,460 |
| 14/26/14 | 47.05 € | +0.66% | 10,64,506 |
Delayed Quote Xetra, January 20, 2026 at 10:05 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SHL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition